• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Aspartate–tRNA ligase, mitochondrial (DARS2)

ACP16346

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP16346 Target NameDARS2
Target SynonymsDARS2; Aspartate--tRNA ligase; mitochondrial; EC 6.1.1.12; Aspartyl-tRNA synthetase; AspRSFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range48-645
Protein LengthFull Length of Mature ProteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ6PI48
Background Information
  • Uniprot Id

    Q6PI48

  • Target Species

    Human

  • Target Name

    DARS2

  • Target Full Name

    Aspartate--tRNA ligase, mitochondrial

  • Target Involvement

    Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL)

  • Target Subcellular Location

    Mitochondrion matrix.

  • Target Protein Families

    Class-II aminoacyl-tRNA synthetase family, Type 1 subfamily

  • Target Synonyms

    DARS2; Aspartate--tRNA ligase; mitochondrial; EC 6.1.1.12; Aspartyl-tRNA synthetase; AspRS

  • Target Background

    The protein encoded by this gene belongs to the class-II aminoacyl-tRNA synthetase family. It is a mitochondrial enzyme that specifically aminoacylates aspartyl-tRNA. Mutations in this gene are associated with leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL).

Inquire Recombinant Human Aspartate–tRNA ligase, mitochondrial (DARS2) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification